Tower Research Capital (TRC)’s Verrica Pharmaceuticals VRCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$14.3K Buy
2,689
+1,165
+76% +$6.18K ﹤0.01% 3842
2025
Q1
$6.74K Buy
1,524
+426
+39% +$1.88K ﹤0.01% 4017
2024
Q4
$7.68K Buy
1,098
+493
+81% +$3.45K ﹤0.01% 4056
2024
Q3
$8.77K Buy
605
+136
+29% +$1.97K ﹤0.01% 3933
2024
Q2
$34.2K Buy
469
+316
+207% +$23K ﹤0.01% 3386
2024
Q1
$9.04K Sell
153
-51
-25% -$3.01K ﹤0.01% 3911
2023
Q4
$15K Sell
204
-177
-46% -$13K ﹤0.01% 3847
2023
Q3
$14.8K Buy
381
+229
+151% +$8.9K ﹤0.01% 3656
2023
Q2
$8.75K Sell
152
-645
-81% -$37.1K ﹤0.01% 4353
2023
Q1
$51K Buy
797
+161
+25% +$10.3K ﹤0.01% 2483
2022
Q4
$18K Sell
636
-69
-10% -$1.95K ﹤0.01% 3240
2022
Q3
$21K Buy
705
+51
+8% +$1.52K ﹤0.01% 3910
2022
Q2
$12K Sell
654
-1,322
-67% -$24.3K ﹤0.01% 4318
2022
Q1
$160K Buy
1,976
+399
+25% +$32.3K ﹤0.01% 1899
2021
Q4
$144K Buy
1,577
+1,500
+1,948% +$137K ﹤0.01% 1995
2021
Q3
$10K Sell
77
-159
-67% -$20.6K ﹤0.01% 4345
2021
Q2
$27K Sell
236
-93
-28% -$10.6K ﹤0.01% 3615
2021
Q1
$50K Sell
329
-153
-32% -$23.3K ﹤0.01% 3131
2020
Q4
$56K Sell
482
-1,133
-70% -$132K ﹤0.01% 3002
2020
Q3
$125K Buy
1,615
+1,348
+505% +$104K ﹤0.01% 2968
2020
Q2
$29K Buy
+267
New +$29K ﹤0.01% 3467
2020
Q1
Sell
-26
Closed -$4K 3966
2019
Q4
$4K Sell
26
-14
-35% -$2.15K ﹤0.01% 2827
2019
Q3
$6K Buy
+40
New +$6K ﹤0.01% 3250
2019
Q2
Sell
-25
Closed -$3K 4357
2019
Q1
$3K Sell
25
-68
-73% -$8.16K ﹤0.01% 3326
2018
Q4
$8K Sell
93
-166
-64% -$14.3K ﹤0.01% 2640
2018
Q3
$42K Buy
+259
New +$42K ﹤0.01% 1876